March 17, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|
Attn:
|
Jeffrey Gabor
|
|
Re:
|
Bionano Genomics, Inc. (the “Company”)
|
|
Registration Statement on Form S-3
|
|
|
Filed: March 11, 2020
|
|
|
File No. 333-237070
|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange
Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement to become effective
at 4:30 p.m. Eastern Time on March 19, 2020 or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact James Pennington of Cooley LLP at (858) 550-6029.
|
Very truly yours,
|
|||
|
Bionano Genomics, Inc.
|
|||
|
By:
|
/s/ R. Erik Holmlin, Ph.D.
|
||
|
R. Erik Holmlin, Ph.D.
|
|||
|
President and Chief Executive Officer
|
|||